Colorectal cancer treatment using bacteria: focus on molecular mechanisms
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Colorectal cancer treatment using bacteria: focus on molecular mechanisms
Authors
Keywords
-
Journal
BMC MICROBIOLOGY
Volume 21, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-07-19
DOI
10.1186/s12866-021-02274-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bacteriocin production by mucosal bacteria in current and previous colorectal neoplasia
- (2020) Darina Kohoutova et al. BMC CANCER
- The bacterial instrument as a promising therapy for colon cancer
- (2020) Atieh Yaghoubi et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Regulatory T cells specifically suppress conventional CD8αβ T cells in intestinal tumors of APCMin/+ mice
- (2020) Louis Szeponik et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Bacteria and cancer: Different sides of the same coin
- (2020) Ghazaleh Laliani et al. LIFE SCIENCES
- The oncogenic roles of bacterial infections in development of cancer
- (2020) Shirin Eyvazi et al. MICROBIAL PATHOGENESIS
- Exploiting Zebrafish Xenografts for Testing the in vivo Antitumorigenic Activity of Microcin E492 Against Human Colorectal Cancer Cells
- (2020) Macarena A. Varas et al. Frontiers in Microbiology
- Epigenetic modifications in gastric cancer: Focus on DNA methylation
- (2020) Vida Ebrahimi et al. GENE
- Effect of Proton Pump Inhibitors on Colorectal Cancer
- (2020) Takamitsu Sasaki et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Bacteriotherapy in gastrointestinal cancer
- (2020) Saman Soleimanpour et al. LIFE SCIENCES
- Bacteriotherapy in Breast Cancer
- (2019) Atieh Yaghoubi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Antimicrobial Peptides (AMPs): Roles, Functions and Mechanism of Action
- (2019) Roghayyeh Seyfi et al. International Journal of Peptide Research and Therapeutics
- The role of bacterial toxins and spores in cancer therapy
- (2019) Lihini Ranesha Weerakkody et al. LIFE SCIENCES
- Targeted Diphtheria Toxin-Based Therapy: A Review Article
- (2019) Fatemeh Shafiee et al. Frontiers in Microbiology
- Bacteria-cancer interactions: bacteria-based cancer therapy
- (2019) Mai Thi-Quynh Duong et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Nisin, a potent bacteriocin and anti-bacterial peptide, attenuates expression of metastatic genes in colorectal cancer cell lines
- (2018) Zohreh Norouzi et al. MICROBIAL PATHOGENESIS
- Bacterial Therapy of Cancer: Promises, Limitations, and Insights for Future Directions
- (2018) M. Gabriela Kramer et al. Frontiers in Microbiology
- The role of bacteria in cancer therapy – enemies in the past, but allies at present
- (2018) Shiyu Song et al. Infectious Agents and Cancer
- Anticancer Activity of Bacterial Proteins and Peptides
- (2018) Tomasz Karpiński et al. Pharmaceutics
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Bacteriocins: perspective for the development of novel anticancer drugs
- (2018) Piyush Baindara et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- LT-IIc, A Bacterial Type II Heat-Labile Enterotoxin, Induces Specific Lethality in Triple Negative Breast Cancer Cells by Modulation of Autophagy and Induction of Apoptosis and Necroptosis
- (2018) Patricia Masso-Welch et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The apoptotic impact of nisin as a potent bacteriocin on the colon cancer cells
- (2017) Shiva Ahmadi et al. MICROBIAL PATHOGENESIS
- Intratumoural production of TNFα by bacteria mediates cancer therapy
- (2017) Carola Murphy et al. PLoS One
- Nonribosomal Peptides from Marine Microbes and Their Antimicrobial and Anticancer Potential
- (2017) Shivankar Agrawal et al. Frontiers in Pharmacology
- Engineered Salmonella enterica serovar Typhimurium overcomes limitations of anti-bacterial immunity in bacteria-mediated tumor therapy
- (2017) Sebastian Felgner et al. OncoImmunology
- Anticancer properties of a defensin like class IId bacteriocin Laterosporulin10
- (2017) Piyush Baindara et al. Scientific Reports
- Spontaneous regression of tumour and the role of microbial infection – possibilities for cancer treatment
- (2016) Petra Kucerova et al. ANTI-CANCER DRUGS
- Analysis of the genomic sequences and metabolites of Serratia surfactantfaciens sp. nov. YD25T that simultaneously produces prodigiosin and serrawettin W2
- (2016) Chun Su et al. BMC GENOMICS
- Activation of multiple chemotherapeutic prodrugs by the natural enzymolome of tumour-localised probiotic bacteria
- (2016) Panos Lehouritis et al. JOURNAL OF CONTROLLED RELEASE
- High-Energy Ball Milling as Green Process To Vitrify Tadalafil and Improve Bioavailability
- (2016) Anna Krupa et al. MOLECULAR PHARMACEUTICS
- Purification and Characterization of Glutaminase Free Asparaginase from Enterobacter cloacae: In-Vitro Evaluation of Cytotoxic Potential against Human Myeloid Leukemia HL-60 Cells
- (2016) Islam Husain et al. PLoS One
- Bacteriocins: Not Only Antibacterial Agents
- (2016) Djamel Drider et al. Probiotics and Antimicrobial Proteins
- Purification, characterization, cytotoxicity and anticancer activities of L-asparaginase, anti-colon cancer protein, from the newly isolated alkaliphilic Streptomyces fradiae NEAE-82
- (2016) Noura El-Ahmady El-Naggar et al. Scientific Reports
- Bacteriocins as Potential Anticancer Agents
- (2015) Sumanpreet Kaur et al. Frontiers in Pharmacology
- Fecal Microbiota Transplantation for the Treatment of Clostridium difficile Infection
- (2014) Giovanni Cammarota et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses
- (2014) N. J. Roberts et al. Science Translational Medicine
- Cloning of ε-poly-L-lysine (ε-PL) synthetase gene from a newly isolated ε-PL-producingStreptomyces albulus NK660 and its heterologous expression inStreptomyces lividans
- (2014) Weitao Geng et al. Microbial Biotechnology
- Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
- (2013) Aleksandar D. Kostic et al. Cell Host & Microbe
- Engineering of Bacteria for the Visualization of Targeted Delivery of a Cytolytic Anticancer Agent
- (2013) Sheng-Nan Jiang et al. MOLECULAR THERAPY
- Standardized Frozen Preparation for Transplantation of Fecal Microbiota for Recurrent Clostridium difficile Infection
- (2012) Matthew J Hamilton et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Optimizing Cancer Treatments to Induce an Acute Immune Response: Radiation Abscopal Effects, PAMPs, and DAMPs
- (2012) C. M. Ludgate CLINICAL CANCER RESEARCH
- Tumor-Associated Antigen Expressing Listeria monocytogenes Induces Effective Primary and Memory T-Cell Responses Against Hepatic Colorectal Cancer Metastases
- (2011) Kelly Olino et al. ANNALS OF SURGICAL ONCOLOGY
- Systematic Review of Intestinal Microbiota Transplantation (Fecal Bacteriotherapy) for Recurrent Clostridium difficile Infection
- (2011) Ethan Gough et al. CLINICAL INFECTIOUS DISEASES
- The Bacterial Protein Azurin Enhances Sensitivity of Oral Squamous Carcinoma Cells to Anticancer Drugs
- (2011) Jeong-Hae Choi et al. YONSEI MEDICAL JOURNAL
- Purification, characterization and in vitro cytotoxicity of the bacteriocin from Pediococcus acidilactici K2a2-3 against human colon adenocarcinoma (HT29) and human cervical carcinoma (HeLa) cells
- (2010) Karen I. Villarante et al. WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY
- Salmonella typhimurium engineered to produce CCL21 inhibit tumor growth
- (2008) Markus Loeffler et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Arenamides A−C, Cytotoxic NFκB Inhibitors from the Marine ActinomyceteSalinispora arenicola⊥
- (2008) Ratnakar N. Asolkar et al. JOURNAL OF NATURAL PRODUCTS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started